What question did this study set out to answer?

To develop and validate a deep learning tool for diagnosing pancreatic cancer on unenhanced CT and risk stratification.

March 26, 2026Radiology Advances0 citationsOpen Access

Pancreatic Cancer Diagnosis on Unenhanced CT with Deep Learning for Opportunistic Diagnosis

Key Points

To develop and validate a deep learning tool for diagnosing pancreatic cancer on unenhanced CT and risk stratification.
Retrospective analysis of 3080 unenhanced CT studies from Taiwanese patients.
Hybrid convolutional neural network–transformer model was trained for diagnosis.
Performance evaluation included sensitivity, specificity, and area under the curve (AUC).
In the internal test set, sensitivity was 90.8% and specificity 93.0% (AUC: 0.98).
In the external test set, sensitivity was 76.2% and specificity 86.4% (AUC: 0.89).
The tool classified cases into seven risk levels with likelihood ratios ranging from <0.01 to 173.46.

Abstract

Abstract Background Pancreatic cancer (PC) is frequently missed on unenhanced CT examinations performed for unrelated clinical indications, where the pancreas is included incidentally and clinical suspicion is low. Purpose To develop and validate a deep learning-based tool for pancreatic cancer diagnosis and risk stratification on unenhanced CT. Materials and Methods This retrospective study included 3080 unenhanced CT studies of Taiwanese patients with PC, other pancreatic diseases and normal pancreas between 2004 and 2019 from a tertiary hospital, randomly divided into training, validation, and internal test sets. Unenhanced CT studies from United States institutions were used for external testing. A hybrid convolutional neural network–transformer model was trained for PC diagnosis and risk stratification. Performance was evaluated using sensitivity, specificity, and area under the curve (AUC), with comparisons to two radiologists by McNemar’s test and exploratory decision curve analysis. Results The internal dataset included 713 PCs (mean age, 64.6 ± 12.0 years; 384 men), 1661 normal pancreas and 706 other pancreatic diseases. In an exploratory comparison restricted to unenhanced CT (29 PCs, 31 controls), the sensitivity of computer-aided diagnosis (CAD) tool (89.7%, 72.6-97.8) seemed comparable with that of one radiologist (86.2%, 68.3–96.1) and higher than another (41.4%, 23.5–61.1); but wide confidence intervals and inter-radiologist variability warrant cautious interpretation. In the internal test set (142 PCs, 474 controls), sensitivity was 90.8% (84.9-95.0) and specificity 93.0% (90.4-95.2) (AUC: 0.98), with sensitivity comparable to radiologist reports based on enhanced and unenhanced CT (95.4%, 90.2-98.3; P = .21). In the external set (42 PCs, 22 controls), sensitivity was 76.2% (60.5-87.9) and specificity 86.4% (65.1-97.1) (AUC: 0.89). The tool stratified cases into seven risk levels with likelihood ratios ranging from 0.01 to 173.46. Exploratory decision curve analysis suggested potential net benefit across threshold probabilities. Conclusion This tool may assist in the opportunistic detection and risk stratification of PC on unenhanced CT.

Ask AI

Helpful

Bookmark

View Full Paper